B/1. Groups of antineoplastic drugs in urology Flashcards
Renal tumors - whats the first choice of treatment
1st choice is surgery (Not sensitive to chemotherapy)
pharmacologic therapy usually only if metastatic
when is pharmacologic therapy used in renal tumors
usually only if metastatic
pharmacological therapy of renal tumors
- Immunotherapy: INF-alpha2, IL-2 (severe toxicity, used previously)
- Chemotherapy: drugs targeting angiogenesis pathways
*Tyrosine kinase inhibitors : VEGFR (sorafenib, sunitinib, axitinib, pazopanib)
*mTOR inhibitors (everolimus, temsirolimus) - Bisphosphonates: in bone metastases
mTOR inhibitors
everolimus, temsirolimus
Tyrosine kinase inhibitors- VEGFR
(sorafenib, sunitinib, axitinib, pazopanib)
Targeted therapy : VEGF blocking drugs
when are bisphosphonates used in renal tumors
in bone metastases
Renal pelvis or ureteric tumors- 1st choice of treatment
1st choice is surgery,
pharmacologic therapy usually only if metastatic
localized disease Renal pelvis or ureteric tumors-
treatment and why is it used
first choice is surgery, if metastatic then:
* adjuvant therapy to reduce risk of recurrence
* Immunotherapy: bacillus Calmette-Guerin (BCG) -> intravesical
* Chemotherapy: mitomycin C (alkylating antibiotic)- pts w/low risk
same as for Non-muscle invasive/superficial Bladder tumors
Advanced and metastatic disease Renal pelvis or ureteric tumors -
what is the treatment? which is better and why?
- urothelial cancer therapy should always be cisplatinum-based
(alkylating agents)
*Gemcitabin/cisplatin protocol is the most widely used - MVAC (MTX, vinblastine, adriamycin/doxorubicin, cisplatin): good response rates, but higher toxicity
Non-muscle invasive/superficial Bladder tumors treatment
- used as adjuvant therapy to reduce risk of recurrence
- Immunotherapy: BCG instillation
- Chemotherapy: mitomycin C, epirubicin, doxorubicin
SAME for localized disease Renal pelvis or ureteric tumor
Muscle-invasive Bladder tumors treatment
- Neo-adjuvant (for operable stages T2-T4a)
- Adjuvant (in locally advanced or LN+ states): cisplatin-based combination chemotherapy
- M-VAC : Methotrexate, Vinblastine, Adriamycin, Cisplatin
- Bone metastases: bisphosphonates, denosumab (RANKL inhibitor)
Testicular tumors stage 2-4 treatment
- stage II-IV should use cisplatin-based chemotherapy
- Chemotherapy if vascular or lymphatic invasion:
-BEP: Bleomycin, Cisplatin 1st line, Etoposide
-PVB: Bleomycin,Cisplatin, Vinblastine
testicular tumor metastasis to ?
lung, bones, liver, and brain
the Paraaortic, retroperitoneal, supradiaphramatic lymph nodes
the chest
pelvis
the base of the neck.
Penile tumors treatment
- adjuvant or neoadjuvant (for fixed inguinal LNs)
- Suggested for advanced disease
MTX
Vincristine
bleomyxin
Cisplatin
docetaxel
5-FU
Prostate tumors treatment in advanced disease
- Hormonal therapy in advanced cases
- Chemical castration with LHRH analogues or antagonists, which might be followed by hormone manipulation w/ antiandrogens
- If castrate-resistance: novel antiandrogens (abiraterone acetate, enzalutamide), docetaxel
- Bone metastases: bisphosphonates, denosumab (RANKL inhibitor), calcium and vitD supplementation